We are live on ! Find out more
PCM

Piermont Capital Management Portfolio holdings

AUM $211M
1-Year Est. Return 8.09%
This Fund
S&P 500
This Quarter Est. Return
+2.61%
1 Year Est. Return
-8.09%
3 Year Est. Return
+33.18%
5 Year Est. Return
+53.13%
10 Year Est. Return
AUM
$420M
AUM Growth
-$18.1M
Cap. Flow
-$22M
Cap. Flow %
-5.25%
Top 10 Hldgs %
10.15%
Holding
292
New
47
Increased
34
Reduced
89
Closed
50

Top Buys

Rank Stock Value
1
RMBS icon
Rambus
RMBS
+$3.25M
2
AVA icon
Avista
AVA
+$3.19M
3
IBKC
IBERIABANK Corp
IBKC
+$3.14M
4
AMKR icon
Amkor Technology
AMKR
+$3.13M
5
WTFC icon
Wintrust Financial
WTFC
+$3.12M

Sector Composition

Rank Sector Weight
1 Financials 20.58%
2 Industrials 17.44%
3 Technology 13.98%
4 Consumer Discretionary 10.56%
5 Healthcare 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OI icon
201
O-I Glass
OI
$1.12B
$715K 0.17%
+35,070
New +$687K
LPX icon
202
Louisiana-Pacific
LPX
$5.27B
$707K 0.17%
+28,490
New +$630K
INGR icon
203
Ingredion
INGR
$6.53B
$706K 0.17%
5,860
+620
+12% +$75.8K
SLGN icon
204
Silgan Holdings
SLGN
$4.44B
$706K 0.17%
+23,780
New +$696K
STBZ
205
DELISTED
State Bank Financial Corporation. Common Stock
STBZ
$688K 0.16%
26,359
-2,410
-8% -$63.8K
LAMR icon
206
Lamar Advertising Co
LAMR
$16.3B
$683K 0.16%
+9,140
New +$686K
VAR
207
DELISTED
Varian Medical Systems, Inc.
VAR
$677K 0.16%
7,430
-1,043
-12% -$87K
LKQ icon
208
LKQ Corp
LKQ
$6.2B
$675K 0.16%
23,076
+11,050
+92% +$344K
SPR
209
DELISTED
Spirit AeroSystems
SPR
$649K 0.15%
11,200
CMD
210
DELISTED
Cantel Medical Corporation
CMD
$642K 0.15%
8,010
TCRT icon
211
Alaunos Therapeutics
TCRT
$4.93M
$639K 0.15%
+672
New +$626K
THFF icon
212
First Financial Corp
THFF
$985M
$632K 0.15%
13,311
-1,210
-8% -$58.1K
PBPB
213
DELISTED
Potbelly
PBPB
$628K 0.15%
+45,208
New +$594K
CYTK icon
214
Cytokinetics
CYTK
$10.8B
$612K 0.15%
+47,618
New +$557K
AKBA icon
215
Akebia Therapeutics
AKBA
$249M
$595K 0.14%
+64,655
New +$631K
PEI
216
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$591K 0.14%
2,602
-7,324
-74% -$1.85M
XNCR icon
217
Xencor
XNCR
$1.46B
$589K 0.14%
24,623
CHH icon
218
Choice Hotels
CHH
$4.95B
$586K 0.14%
+9,360
New +$550K
CASY icon
219
Casey's General Stores
CASY
$30.3B
$583K 0.14%
5,190
STLD icon
220
Steel Dynamics
STLD
$37.9B
$583K 0.14%
16,760
+1,490
+10% +$53.1K
MUSA icon
221
Murphy USA
MUSA
$9.72B
$579K 0.14%
7,880
KSS icon
222
Kohl's
KSS
$2.19B
$573K 0.14%
14,400
REGI
223
DELISTED
Renewable Energy Group, Inc.
REGI
$568K 0.14%
54,350
URBN icon
224
Urban Outfitters
URBN
$6.7B
$563K 0.13%
23,680
ARRY
225
DELISTED
Array Biopharma Inc
ARRY
$562K 0.13%
+62,900
New +$669K

Similar funds

Piermont Capital Management's Q1 2017 Portfolio in Review

As of Q1 2017, Piermont Capital Management held 292 positions worth $420M, down 4.1% from $438M the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Piermont Capital Management withdrew a net $22M in Q1 2017, closing 50 positions and reducing 89 holdings. Its most notable exit was Piper Sandler, an estimated $4.11M position sold in full.

By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 21% a quarter earlier, followed by Industrials and Technology.

Against the trend, Piermont Capital Management opened a new position in Avista worth $3.18M.

  • Piermont Capital Management's largest Q1 2017 buy was Avista: 81,350 shares worth $3.18M.
  • Piermont Capital Management added most to Rambus in Q1 2017, an estimated $3.25M increase.
  • Piermont Capital Management's biggest Q1 2017 reduction was Pennsylvania Real Estate Investment Trust, cutting an estimated $1.85M.
  • Piermont Capital Management fully exited Piper Sandler in Q1 2017, selling an estimated $4.11M.
  • Piermont Capital Management's ten largest holdings make up 10% of its $420M portfolio in Q1 2017.
  • Piermont Capital Management opened 47 new positions and closed 50 in Q1 2017.
  • Piermont Capital Management's portfolio value fell 4.1% quarter-over-quarter to $420M.

Based on Piermont Capital Management's 13F filing for Q1 2017, filed 11 May 2017.